Acute Liver Injury due to Glecaprevir/Pibrentasvir in a Patient with Chronic Hepatitis C Virus Infection without Cirrhosis-Reference-Cited by-同舟云学术

Acute Liver Injury due to Glecaprevir/Pibrentasvir in a Patient with Chronic Hepatitis C Virus Infection without Cirrhosis

Published:2022-07 Issue:03 Volume:12 Page:154-156
ISSN:2231-0770
Container-title:Avicenna Journal of Medicine
language:en
Short-container-title:Avicenna J Med

Author:

Jain Ayushi¹^ORCID,Mumtaz Khalid²

Affiliation:

1. Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States

2. Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States

Abstract

AbstractWe reported a rare case of acute liver injury in a patient with chronic hepatitis C virus infection without cirrhosis 4 weeks after initiation of glecaprevir/pibrentasvir. After prompt cessation of antiviral therapy, liver enzymes rapidly improved toward baseline. This case reflects the need to remain vigilant for the development of acute liver injury after initiation of glecaprevir/pibrentasvir even without a diagnosis of cirrhosis.

Publisher

Georg Thieme Verlag KG

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0042-1750716.pdf

Reference7 articles.

1. Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland;B Müllhaupt;Swiss Med Wkly,2021

2. A case report of glecaprevir/pibrentasvir-induced severe hyperbilirubinemia in a patient with compensated liver cirrhosis;J H Yoon;Medicine (Baltimore),2019

3. A method for estimating the probability of adverse drug reactions;C A Naranjo;Clin Pharmacol Ther,1981

4. EASL recommendations on treatment of hepatitis C: final update of the series☆;European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu;J Hepatol,2020

5. Glecaprevir/pibrentasvir-associated acute liver injury in non-cirrhotic, chronic HCV infection without HBV co-infection;M B Hammami;BMJ Case Rep,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glecaprevir-Pibrentasvir and Ethinyl Estradiol-Induced Liver Injury in a Patient Without Cirrhosis;Cureus;2024-06-08

2. Old age as a risk factor for liver diseases: Modern therapeutic approaches;Experimental Gerontology;2023-12

3. Risk Factors of Glecaprevir/Pibrentasvir-Induced Liver Injury and Efficacy of Ursodeoxycholic Acid;Viruses;2023-02-09